Shares of Smith & Nephew Plc (NYSE:SNN) are trading higher on Friday. Smith+Nephew offers a medical technology portfolio across orthopedics, sports medicine, ENT, and advanced wound management. In an SEC filing, Smith & Nephew reported that an activist investor, Cevian Capital, had taken a 5% stake. Citing a partner at the Swedish fund, Bloomberg noted that Smith & Nephew has not generated shareholder value for many years. “Cevian sees the potential to create significant long-term value by improving the operating performance of the company’s businesses.” Medical technology firm’s share price performance in the past five years has been lacklustre. Its ...